Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAGRAF-IKUR study of S066913 in paroxysmal atrial fibrillation
NL-OMON41862Phase 2Active, not recruiting
- Sponsor
- Servier
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S066913 in Atrial fibrillation (AFib) (4 arms), sponsored by Servier. Primary endpoint: Absolute change from baseline in AF/AT burden. Started Apr 2015; status: active, not recruiting.
02
Drugs
S066913
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON41862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41862.